157 related articles for article (PubMed ID: 12480514)
1. Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.
Chen S; Iglesias-de la Cruz MC; Jim B; Hong SW; Isono M; Ziyadeh FN
Biochem Biophys Res Commun; 2003 Jan; 300(1):16-22. PubMed ID: 12480514
[TBL] [Abstract][Full Text] [Related]
2. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
Ziyadeh FN; Hoffman BB; Han DC; Iglesias-De La Cruz MC; Hong SW; Isono M; Chen S; McGowan TA; Sharma K
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8015-20. PubMed ID: 10859350
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice.
Sharma K; Jin Y; Guo J; Ziyadeh FN
Diabetes; 1996 Apr; 45(4):522-30. PubMed ID: 8603776
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.
Flyvbjerg A; Dagnaes-Hansen F; De Vriese AS; Schrijvers BF; Tilton RG; Rasch R
Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452
[TBL] [Abstract][Full Text] [Related]
6. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
7. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice.
Shibuya K; Kanasaki K; Isono M; Sato H; Omata M; Sugimoto T; Araki S; Isshiki K; Kashiwagi A; Haneda M; Koya D
Diabetes; 2005 Mar; 54(3):838-45. PubMed ID: 15734863
[TBL] [Abstract][Full Text] [Related]
8. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
9. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
[TBL] [Abstract][Full Text] [Related]
10. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
11. Prevention of decline in renal function in the diabetic db/db mouse.
Cohen MP; Clements RS; Cohen JA; Shearman CW
Diabetologia; 1996 Mar; 39(3):270-4. PubMed ID: 8721771
[TBL] [Abstract][Full Text] [Related]
12. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
[TBL] [Abstract][Full Text] [Related]
13. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
14. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
[TBL] [Abstract][Full Text] [Related]
15. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
16. Soluble betaglycan reduces renal damage progression in db/db mice.
Juárez P; Vilchis-Landeros MM; Ponce-Coria J; Mendoza V; Hernández-Pando R; Bobadilla NA; López-Casillas F
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F321-9. PubMed ID: 16954341
[TBL] [Abstract][Full Text] [Related]
17. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.
Guo M; Ricardo SD; Deane JA; Shi M; Cullen-McEwen L; Bertram JF
J Anat; 2005 Dec; 207(6):813-21. PubMed ID: 16367807
[TBL] [Abstract][Full Text] [Related]
18. Studies of the glomerular mesangium and the juxtaglomerular apparatus in the genetically diabetic mouse.
Bower G; Brown DM; Steffes MW; Vernier RL; Mauer SM
Lab Invest; 1980 Oct; 43(4):333-41. PubMed ID: 7003252
[TBL] [Abstract][Full Text] [Related]
19. Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.
Zheng F; Cornacchia F; Schulman I; Banerjee A; Cheng QL; Potier M; Plati AR; Berho M; Elliot SJ; Li J; Fornoni A; Zang YJ; Zisman A; Striker LJ; Striker GE
Diabetes; 2004 Sep; 53(9):2420-7. PubMed ID: 15331554
[TBL] [Abstract][Full Text] [Related]
20. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S; Hong SW; Iglesias-de la Cruz MC; Isono M; Casaretto A; Ziyadeh FN
Ren Fail; 2001; 23(3-4):471-81. PubMed ID: 11499562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]